Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project).


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
08 2021
Historique:
received: 06 03 2020
accepted: 17 08 2020
pubmed: 29 8 2020
medline: 21 10 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Aim of this study was to evaluate and compare perioperative outcomes of transperitoneal (TP) and retroperitoneal (TR) approaches in a multi-institutional cohort of minimally invasive partial nephrectomy (MI-PN). All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 project) between 01/2013 and 12/2016 were evaluated, collecting the pre-, intra-, and postoperative data. The patients were then stratified according to the surgical approach, TP or RP. A 1:1 propensity score (PS) matching was performed to obtain homogeneous cohorts, considering the age, gender, baseline eGFR, surgical indication, clinical diameter, and PADUA score. 1669 patients treated with MI-PN were included in the study, 1256 and 413 undergoing TP and RP, respectively. After 1:1 PS matching according to the surgical access, 413 patients were selected from TP group to be compared with the 413 RP patients. Concerning intraoperative variables, no differences were found between the two groups in terms of surgical approach (lap/robot), extirpative technique (enucleation vs standard PN), hilar clamping, and ischemia time. Conversely, the TP group recorded a shorter median operative time in comparison with the RP group (115 vs 150 min), with a higher occurrence of intraoperative overall, 21 (5.0%) vs 9 (2.1%); p = 0.03, and surgical complications, 18 (4.3%) vs 7 (1.7%); p = 0.04. Concerning postoperative variables, the two groups resulted comparable in terms of complications, positive surgical margins and renal function, even if the RP group recorded a shorter median drainage duration and hospital length of stay (3 vs 2 for both variables), p < 0.0001. The results of this study suggest that both TP and RP are feasible approaches when performing MI-PN, irrespectively from tumor location or surgical complexity. Notwithstanding longer operative times, RP seems to have a slighter intraoperative complication rate with earlier postoperative recovery when compared with TP.

Sections du résumé

BACKGROUND
Aim of this study was to evaluate and compare perioperative outcomes of transperitoneal (TP) and retroperitoneal (TR) approaches in a multi-institutional cohort of minimally invasive partial nephrectomy (MI-PN).
MATERIAL AND METHODS
All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 project) between 01/2013 and 12/2016 were evaluated, collecting the pre-, intra-, and postoperative data. The patients were then stratified according to the surgical approach, TP or RP. A 1:1 propensity score (PS) matching was performed to obtain homogeneous cohorts, considering the age, gender, baseline eGFR, surgical indication, clinical diameter, and PADUA score.
RESULTS
1669 patients treated with MI-PN were included in the study, 1256 and 413 undergoing TP and RP, respectively. After 1:1 PS matching according to the surgical access, 413 patients were selected from TP group to be compared with the 413 RP patients. Concerning intraoperative variables, no differences were found between the two groups in terms of surgical approach (lap/robot), extirpative technique (enucleation vs standard PN), hilar clamping, and ischemia time. Conversely, the TP group recorded a shorter median operative time in comparison with the RP group (115 vs 150 min), with a higher occurrence of intraoperative overall, 21 (5.0%) vs 9 (2.1%); p = 0.03, and surgical complications, 18 (4.3%) vs 7 (1.7%); p = 0.04. Concerning postoperative variables, the two groups resulted comparable in terms of complications, positive surgical margins and renal function, even if the RP group recorded a shorter median drainage duration and hospital length of stay (3 vs 2 for both variables), p < 0.0001.
CONCLUSIONS
The results of this study suggest that both TP and RP are feasible approaches when performing MI-PN, irrespectively from tumor location or surgical complexity. Notwithstanding longer operative times, RP seems to have a slighter intraoperative complication rate with earlier postoperative recovery when compared with TP.

Identifiants

pubmed: 32856156
doi: 10.1007/s00464-020-07919-4
pii: 10.1007/s00464-020-07919-4
pmc: PMC8263535
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4295-4304

Investigateurs

Vincenzo Altieri (V)
Francesco Berardinelli (F)
Antonio Celia (A)
Elisabetta Costantini (E)
Alberto Diminutto (A)
Mario Falsaperla (M)
Matteo Ferro (M)
Maria Furlan (M)
Gaetano Grosso (G)
Alessandro Larcher (A)
Vincenzo Li Marzi (V)
Francesco Montorsi (F)
Andrea Polara (A)
Angelo Porreca (A)
Riccardo Rizzetto (R)
Marco Roscigno (M)
Luigi Schips (L)
Cesare Selli (C)
Sergio Serni (S)
Alchiede Simonato (A)
Carlo Trombetta (C)
Giuseppe Vespasiani (G)
Alessandro Volpe (A)

Références

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M et al (2015) EAU guidelines for renal cell carcinoma: 2014 update. Eur Urol 67:913–924. https://doi.org/10.1016/j.eururo.2015.01.005
doi: 10.1016/j.eururo.2015.01.005 pubmed: 25616710
Ali S, Ahn T, Papa N, Perera M, Teloken P, Coughlin G et al (2019) Changing trends in surgical management of renal tumours from 2000 to 2016: a nationwide study of Medicare claims data. ANZ J Surg. https://doi.org/10.1111/ans.15385
doi: 10.1111/ans.15385 pubmed: 31478323
Minervini A, Rosaria Raspollini M, Tuccio A, Di Cristofano C, Siena G, Salvi M et al (2014) Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation. Urol Oncol 32(50):e15–22. https://doi.org/10.1016/j.urolonc.2013.07.018
doi: 10.1016/j.urolonc.2013.07.018
Li J, Zhang Y, Teng Z, Han Z (2019) Partial nephrectomy versus radical nephrectomy for cT2 or greater renal tumors: a systematic review and meta-analysis. Minerva Urol Nefrol 71:435–444. https://doi.org/10.23736/S0393-2249.19.03470-2
doi: 10.23736/S0393-2249.19.03470-2 pubmed: 31287256
Larcher A, Capitanio U, Terrone C, Volpe A, De Angelis P, Deho F et al (2016) Elective nephron sparing surgery decreases other cause mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol 196:1008–1013. https://doi.org/10.1016/j.juro.2016.04.093
doi: 10.1016/j.juro.2016.04.093 pubmed: 27235789
Capitanio U, Larcher A, Terrone C, Antonelli A, Volpe A, Fiori C et al (2016) End-stage renal disease after renal surgery in patients with normal preoperative kidney function: balancing surgical strategy and individual disorders at baseline. Eur Urol. https://doi.org/10.1016/j.eururo.2016.03.023
doi: 10.1016/j.eururo.2016.03.023 pubmed: 27692706
Veccia A, Dell’oglio P, Antonelli A, Minervini A, Simone G, Challacombe B et al (2019) Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses. Minerva Urol Nefrol. https://doi.org/10.23736/S0393-2249.19.03583-5
doi: 10.23736/S0393-2249.19.03583-5 pubmed: 31833720
Serni S, Vittori G, Frizzi J, Mari A, Siena G, Lapini A et al (2015) Simple enucleation for the treatment of highly complex renal tumors: perioperative, functional and oncological results. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2015.02.019
doi: 10.1016/j.ejso.2015.02.019 pubmed: 25957967
Mari A, Campi R, Schiavina R, Amparore D, Antonelli A, Artibani W et al (2019) Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy : a prospective multicentre observational study (the RECORd 2 project). BJU Int. https://doi.org/10.1111/bju.14680
doi: 10.1111/bju.14680 pubmed: 30653796
Fan X, Xu K, Lin T, Liu H, Yin Z, Dong W et al (2013) Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: a systematic review and meta-analysis. BJU Int 111:611–621. https://doi.org/10.1111/j.1464-410X.2012.11598.x
doi: 10.1111/j.1464-410X.2012.11598.x pubmed: 23106964
Ren T, Liu Y, Zhao X, Ni S, Zhang C, Guo C et al (2014) Transperitoneal approach versus retroperitoneal approach: a meta-analysis of laparoscopic partial nephrectomy for renal cell carcinoma. PLoS ONE 9:e91978. https://doi.org/10.1371/journal.pone.0091978
doi: 10.1371/journal.pone.0091978 pubmed: 24658032 pmcid: 3962363
Ng CS, Gill IS, Ramani AP, Steinberg AP, Spaliviero M, Abreu SC et al (2005) Transperitoneal versus retroperitoneal laparoscopic partial nephrectomy: patient selection and perioperative outcomes. J Urol 174:846–849. https://doi.org/10.1097/01.ju.0000169259.49754.02
doi: 10.1097/01.ju.0000169259.49754.02 pubmed: 16093967
Fu J, Ye S, Ye H (2015) Retroperitoneal versus transperitoneal laparoscopic partial nephrectomy: a systematic review and meta-analysis. Chin Med Sci J Chung-Kuo i Hsueh k’o Hsueh Tsa Chih 30:239–244. https://doi.org/10.1016/s1001-9294(16)30007-4
doi: 10.1016/s1001-9294(16)30007-4 pubmed: 26960305
Porpiglia F, Mari A, Bertolo R, Antonelli A, Bianchi G, Fidanza F et al (2016) Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the RECORd Project). Urology 89:45–51. https://doi.org/10.1016/j.urology.2015.08.049
doi: 10.1016/j.urology.2015.08.049 pubmed: 26743388
Arora S, Heulitt G, Menon M, Jeong W, Ahlawat RK, Capitanio U et al (2018) Retroperitoneal vs transperitoneal robot-assisted partial nephrectomy: comparison in a multi-institutional setting. Urology 120:131–137. https://doi.org/10.1016/j.urology.2018.06.026
doi: 10.1016/j.urology.2018.06.026 pubmed: 30053396
Schiavina R, Mari A, Antonelli A, Bertolo R, Bianchi G, Borghesi M et al (2015) A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project). Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2014.12.001
doi: 10.1016/j.ejso.2014.12.001 pubmed: 25583459
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399–424. https://doi.org/10.1080/00273171.2011.568786
doi: 10.1080/00273171.2011.568786 pubmed: 21818162 pmcid: 3144483
Mari A, Antonelli A, Bertolo R, Bianchi G, Borghesi M, Ficarra V et al (2017) Predictive factors of overall and major postoperative complications after partial nephrectomy: results from a multicenter prospective study (The RECORd 1 project). Eur J Surg Oncol 43:823–830. https://doi.org/10.1016/j.ejso.2016.10.016
doi: 10.1016/j.ejso.2016.10.016 pubmed: 27876194
Minervini A, Siena G, Antonelli A, Bianchi G, Bocciardi AM, Cosciani Cunico S et al (2014) Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). World J Urol. https://doi.org/10.1007/s00345-013-1155-7
doi: 10.1007/s00345-013-1155-7 pubmed: 24013181
Grivas N, Kalampokis N, Larcher A, Tyritzis S, Rha KH, Ficarra V et al (2019) Robot-assisted versus open partial nephrectomy: comparison of outcomes. A systematic review. Minerva Urol Nefrol 71:113–120. https://doi.org/10.23736/S0393-2249.19.03391-5
doi: 10.23736/S0393-2249.19.03391-5 pubmed: 30895768
Bravi CA, Larcher A, Capitanio U, Mari A, Antonelli A, Artibani W et al (2019) Perioperative outcomes of open, laparoscopic, and robotic partial nephrectomy: a prospective multicenter observational study (The RECORd 2 Project). Eur Urol Focus. https://doi.org/10.1016/j.euf.2019.10.013
doi: 10.1016/j.euf.2019.10.013 pubmed: 31727523
Desai MM, Strzempkowski B, Matin SF, Steinberg AP, Ng C, Meraney AM et al (2005) Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol 173:38–41. https://doi.org/10.1097/01.ju.0000145886.26719.73
doi: 10.1097/01.ju.0000145886.26719.73 pubmed: 15592021
Khandwala YS, Jeong IG, Han DH, Kim JH, Li S, Wang Y et al (2017) Surgeon preference of surgical approach for partial nephrectomy in patients with baseline chronic kidney disease: a nationwide population-based analysis in the USA. Int Urol Nephrol 49:1921–1927. https://doi.org/10.1007/s11255-017-1688-6
doi: 10.1007/s11255-017-1688-6 pubmed: 28852937
Gin GE, Maschino AC, Spaliviero M, Vertosick EA, Bernstein ML, Coleman JA (2014) Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity. Urology 84:1355–1360. https://doi.org/10.1016/j.urology.2014.07.045
doi: 10.1016/j.urology.2014.07.045 pubmed: 25288573
Pavan N, Derweesh I, Hampton LJ, White WM, Porter J, Challacombe BJ et al (2018) Retroperitoneal robotic partial nephrectomy: systematic review and cumulative analysis of comparative outcomes. J Endourol 32:591–596. https://doi.org/10.1089/end.2018.0211
doi: 10.1089/end.2018.0211 pubmed: 29695171
Laviana AA, Tan H-J, Hu JC, Weizer AZ, Chang SS, Barocas DA (2018) Retroperitoneal versus transperitoneal robotic-assisted laparoscopic partial nephrectomy: a matched-pair, bicenter analysis with cost comparison using time-driven activity-based costing. Curr Opin Urol 28:108–114. https://doi.org/10.1097/MOU.0000000000000483
doi: 10.1097/MOU.0000000000000483 pubmed: 29278580
Paulucci DJ, Beksac AT, Porter J, Abaza R, Eun DD, Bhandari A et al (2019) A multi-institutional propensity score matched comparison of transperitoneal and retroperitoneal partial nephrectomy for cT1 posterior tumors. J Laparoendosc Adv Surg Tech A 29:29–34. https://doi.org/10.1089/lap.2018.0313
doi: 10.1089/lap.2018.0313 pubmed: 30106606
Choi C, Kang M, Sung HH, Jeon HG, Jeong BC, Jeon SS et al (2019) Comparison by pentafecta criteria of transperitoneal and retroperitoneal robotic partial nephrectomy for large renal tumors. J Endourol. https://doi.org/10.1089/end.2019.0410
doi: 10.1089/end.2019.0410 pubmed: 31621405
McLean A, Mukherjee A, Phukan C, Veeratterapillay R, Soomro N, Somani B et al (2019) Trans-peritoneal vs. retroperitoneal robotic assisted partial nephrectomy in posterior renal tumours: need for a risk-stratified patient individualised approach. A systematic review and meta-analysis. J Robot Surg. https://doi.org/10.1007/s11701-019-00973-8
doi: 10.1007/s11701-019-00973-8 pubmed: 31089965
Xia L, Zhang X, Wang X, Xu T, Qin L, Zhang X et al (2016) Transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a systematic review and meta-analysis. Int J Surg 30:109–115. https://doi.org/10.1016/j.ijsu.2016.04.023
doi: 10.1016/j.ijsu.2016.04.023 pubmed: 27107660

Auteurs

Francesco Porpiglia (F)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Andrea Mari (A)

Department of Urology, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, University of Florence, Florence, Italy.

Daniele Amparore (D)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Cristian Fiori (C)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Alessandro Antonelli (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Walter Artibani (W)

Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy.

Pierluigi Bove (P)

Department of Urology, University Hospital of Tor Vergata, Rome, Italy.

Eugenio Brunocilla (E)

Department of Urology, University of Bologna, Bologna, Italy.
Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

Umberto Capitanio (U)

Unit of Urology, Division of Experimental Oncology, URI-Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Luigi Da Pozzo (L)

Department of Urology, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Fabrizio Di Maida (F)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Paolo Gontero (P)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Nicola Longo (N)

Department of Urology, University Federico II of Naples, Naples, Italy.

Giancarlo Marra (G)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Bernardo Rocco (B)

Department of Urology, Fondazione IRCCS Ca' Granda' Ospedale Maggiore Policlinico' Policlinico' University of Milan, Milan, Italy.
Department of Urology, University of Modena and Reggio Emilia, Modena, Italy.

Riccardo Schiavina (R)

Department of Urology, University of Bologna, Bologna, Italy.

Claudio Simeone (C)

Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Salvatore Siracusano (S)

Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy.

Riccardo Tellini (R)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Carlo Terrone (C)

Department of Urology, University of Genova, Genova, Italy.

Donata Villari (D)

Department of Urology, Unit of Urological Minimally Invasive Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.

Vincenzo Ficarra (V)

Department of Human and Paediatric Pathology, Gaetano Barresi, Urologic Section, University of Messina, Messina, Italy.

Marco Carini (M)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Andrea Minervini (A)

Division of Urology, Department of Oncology- School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy. andreamine@libero.it.
Department of Urology, Careggi Hospital, San Luca Nuovo, University of Florence, Florence, Italy. andreamine@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH